103 related articles for article (PubMed ID: 26616441)
21. Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK.
Zhu Y; Zhang T; Xie S; Tu R; Cao Y; Guo X; Zhou J; Zhou X; Cao L
Biomed Pharmacother; 2012 Dec; 66(8):569-77. PubMed ID: 23102719
[TBL] [Abstract][Full Text] [Related]
22. Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.
Novella-Maestre E; Herraiz S; Vila-Vives JM; Carda C; Ruiz-Sauri A; Pellicer A
Fertil Steril; 2012 Nov; 98(5):1209-17. PubMed ID: 22921078
[TBL] [Abstract][Full Text] [Related]
23. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
[TBL] [Abstract][Full Text] [Related]
24. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma.
Gamage SD; Bischoff ED; Burroughs KD; Lamph WW; Gottardis MM; Walker CL; Fuchs-Young R
J Pharmacol Exp Ther; 2000 Nov; 295(2):677-81. PubMed ID: 11046105
[TBL] [Abstract][Full Text] [Related]
27. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
Islam MS; Protic O; Ciavattini A; Giannubilo SR; Tranquilli AL; Catherino WH; Castellucci M; Ciarmela P
Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
[TBL] [Abstract][Full Text] [Related]
28. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
Mizutani T; Sugihara A; Nakamuro K; Terada N
J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
[TBL] [Abstract][Full Text] [Related]
29. Oxytocin-induced cell growth proliferation in human myometrial cells and leiomyomas.
Busnelli M; Rimoldi V; Viganò P; Persani L; Di Blasio AM; Chini B
Fertil Steril; 2010 Oct; 94(5):1869-74. PubMed ID: 20056210
[TBL] [Abstract][Full Text] [Related]
30. Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin.
Kim DC; Ramachandran S; Baek SH; Kwon SH; Kwon KY; Cha SD; Bae I; Cho CH
Reprod Sci; 2008 Jul; 15(6):552-8. PubMed ID: 18487228
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050.
Shushan A; Ben-Bassat H; Mishani E; Laufer N; Klein BY; Rojansky N
Fertil Steril; 2007 Jan; 87(1):127-35. PubMed ID: 17074332
[TBL] [Abstract][Full Text] [Related]
32. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
[TBL] [Abstract][Full Text] [Related]
33. Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids.
Salama SA; Nasr AB; Dubey RK; Al-Hendy A
J Soc Gynecol Investig; 2006 Dec; 13(8):542-50. PubMed ID: 17088081
[TBL] [Abstract][Full Text] [Related]
34. Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent.
Gilden M; Malik M; Britten J; Delgado T; Levy G; Catherino WH
Fertil Steril; 2012 Dec; 98(6):1557-62. PubMed ID: 22925684
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice.
Tsuiji K; Takeda T; Li B; Kondo A; Ito M; Yaegashi N
Tohoku J Exp Med; 2010 Sep; 222(1):55-61. PubMed ID: 20814179
[TBL] [Abstract][Full Text] [Related]
36. Fucoidan Inhibits the Proliferation of Leiomyoma Cells and Decreases Extracellular Matrix-Associated Protein Expression.
Chen HY; Huang TC; Lin LC; Shieh TM; Wu CH; Wang KL; Hong YH; Hsia SM
Cell Physiol Biochem; 2018; 49(5):1970-1986. PubMed ID: 30235439
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
[TBL] [Abstract][Full Text] [Related]
38. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.
Ozawa Y; Murakami T; Tamura M; Terada Y; Yaegashi N; Okamura K
Fertil Steril; 2006 Oct; 86(4 Suppl):1146-51. PubMed ID: 16962108
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
[TBL] [Abstract][Full Text] [Related]
40. [Morpho- and angiogenetic characteristics of uterine leiomyoma].
Zaĭrat'iants OV; Sidorova IS; Levakov SA; Levin EM; Opalenov KV
Arkh Patol; 2005; 67(3):29-31. PubMed ID: 16075609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]